Preclinical Evaluation of an Inhibitor of Cytosolic Phospholipase A(2)alpha for the Treatment of Asthma / Hewson, Ca; Patel, S; Calzetta, L; Campwala, H; Havard, S; Luscombe, E; Clarke, Pa; Peachell, Pt; Matera, Mg; Cazzola, M; Page, C; Abraham, Wm; Williams, Cm; Clark, Jd; Liu, Wl; Clarke, Np; Yeadon, M. - In: THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. - ISSN 0022-3565. - 340:3(2012), pp. 656-665. [10.1124/jpet.111.186379]

Preclinical Evaluation of an Inhibitor of Cytosolic Phospholipase A(2)alpha for the Treatment of Asthma

Calzetta L;
2012-01-01

2012
Preclinical Evaluation of an Inhibitor of Cytosolic Phospholipase A(2)alpha for the Treatment of Asthma / Hewson, Ca; Patel, S; Calzetta, L; Campwala, H; Havard, S; Luscombe, E; Clarke, Pa; Peachell, Pt; Matera, Mg; Cazzola, M; Page, C; Abraham, Wm; Williams, Cm; Clark, Jd; Liu, Wl; Clarke, Np; Yeadon, M. - In: THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. - ISSN 0022-3565. - 340:3(2012), pp. 656-665. [10.1124/jpet.111.186379]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2878154
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 29
social impact